Capital raised by Senti Biosciences
1 Form D filing · first filed May 2026 · South San Francisco, CA
Executive Officer
Listed on Senti Biosciences's Form D filings · President, Head of Research and Development and Chief Medical Officer of Senti Biosciences Holdings, Inc.
Kanya Rajangam is on file as Executive Officer at Senti Biosciences in South San Francisco, CA. Senti Biosciences has 1 Form D filing on record, $10.0M raised in total. President, Head of Research and Development and Chief Medical Officer of Senti Biosciences Holdings, Inc.
A proprietary technology platform integrating synthetic biology and AI to enable dynamic, post-administration control of genetic medicines, letting the expression of a delivered therapy be tuned after it is already in the patient. It is the company's go-forward focus following the July 2026 spin-out of the gene-circuit pipeline.
